Login / Signup

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.

Dima KabbaniDemitra M YotisVictor H FerreiraSarah ShalhoubSara BelgaVaralika TyagiMatthew IerulloVathany KulasingamMarie-Josée HébertLori WestJean-Sébastien DelisleNormand RacineSacha A De SerresHéloïse CardinalMélanie DieudéAtul HumarDeepali Kumar
Published in: Open forum infectious diseases (2023)
Three or four doses of COVID-19 vaccines were safe, increased immunogenicity, and protected against severe disease requiring hospitalization. Infection paired with multiple vaccinations significantly increased anti-RBD response. However, SOT populations should continue to practice infection prevention measures, and they should be prioritized for SARS-CoV-2 pre-exposure prophylactics and early therapeutics.
Keyphrases
  • respiratory syndrome coronavirus
  • coronavirus disease
  • sars cov
  • primary care
  • healthcare
  • early onset
  • clinical trial
  • cross sectional